ArticleNature materials2023
Author Correction: Tissue fluidification promotes a cGAS-STING cytosolic DNA response in invasive breast cancer.
Abstract readPublished Erratum
In one paragraph
Article in Nature materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
47 authors.
Emanuela Frittoli *IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Andrea Palamidessi *IFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. andrea.palamidessi@ifom.eu.ORCID http://orcid.org/0000-0002-7134-7023
Fabio IannelliIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-2777-1417
Federica ZanardiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Stefano VillaDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, Italy.
Leonardo BarzaghiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-3174-6441
Hind AbdoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Valeria CancilaDepartment of Health Sciences, Human Pathology Section, University of Palermo School of Medicine, Palermo, Italy.
Galina V BeznoussenkoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-1876-4098
Giulia Della ChiaraIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0001-5211-3814
Massimiliano PaganiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Chiara MalinvernoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Dipanjan BhattacharyaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-6409-4291
Federica PisatiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Weimiao YuInstitute of Molecular and Cell Biology, A*STAR, Singapore, & Bioinformatics Institute, A*STAR, Singapore, Singapore.ORCID http://orcid.org/0000-0001-5092-1009
Viviana GalimbertiEuropean Institute of Oncology (IEO) IRCCS, Milan, Italy.
Giuseppina BonizziEuropean Institute of Oncology (IEO) IRCCS, Milan, Italy.
Emanuele MartiniIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0002-3375-7726
Alexander A MironovIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Ubaldo GioiaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Flora AscioneIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Qingsen LiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Kristina HavasIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Serena MagniIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0003-4730-9710
Zeno LavagninoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Fabrizio Andrea PennacchioIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Paolo MaiuriIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.ORCID http://orcid.org/0000-0001-5079-445X
Silvia CaponiIstituto Officina dei Materiali, National Research Council (IOM-CNR), Unit of Perugia, c/o Department of Physics and Geology, University of Perugia, Perugia, Italy.ORCID http://orcid.org/0000-0002-4219-3256
Maurizio MattarelliDepartment of Physics and Geology, University of Perugia, Perugia, Italy.ORCID http://orcid.org/0000-0001-9184-7968
Sabata MartinoDepartment of Chemistry, Biology and Biotechnology, Biochemical and Biotechnological Sciences, University of Perugia, Perugia, Italy.
Fabrizio d'Adda di FagagnaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Chiara RossiUnit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0000-0002-9253-1671
Marco LucioniUnit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
Richard TancrediMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Paolo PedrazzoliMedical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.ORCID http://orcid.org/0000-0002-9419-7160
Andrea VecchioneDepartment of Clinical and Molecular Medicine, University of Roma, La Sapienza, Rome, Italy.ORCID http://orcid.org/0000-0002-5497-6856
Cristiano PetriniIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Francesco FerrariIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Chiara LanzuoloInstitute of Biomedical Technologies, National Research Council, Milan, Italy.
Giovanni BertalotDepartment of Pathology, S. Chiara Hospital, Azienda Provinciale per i Servizi Sanitari, Trento, Italy.
Guilherme NaderInstitut Curie and Institut Pierre Gilles de Gennes, PSL Research University, CNRS, UMR-144, Paris, France.
Marco FoianiIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy.
Matthieu PielInstitut Curie and Institut Pierre Gilles de Gennes, PSL Research University, CNRS, UMR-144, Paris, France.ORCID http://orcid.org/0000-0002-2848-177X
Roberto CerbinoDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, Italy.ORCID http://orcid.org/0000-0003-0434-7741
Fabio GiavazziDepartment of Medical Biotechnology and Translational Medicine, University of Milan, Segrate, Italy. fabio.giavazzi@unimi.it.ORCID http://orcid.org/0000-0003-4930-0592
Claudio TripodoIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. claudio.tripodo@unipa.it.ORCID http://orcid.org/0000-0002-0821-6231
Giorgio ScitaIFOM, the FIRC Institute of Molecular Oncology, Milan, Italy. giorgio.scita@ifom.eu.ORCID http://orcid.org/0000-0001-7984-1889
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.